TAPUR Trial Leverages Genomic Testing for Precision Medicine

June 21, 2017

In this video, Dr. Edward Kim provides details on the TAPUR trial, which uses broad genomic test results to aid in precision medicine for cancer patients.

Edward Kim, MD, FACP, of the Levine Cancer Institute, Carolinas Healthcare System, in Charlotte, North Carolina, discusses aspects of the ASCO-led TAPUR trial, which utilizes genomic testing to identify markers that can be targeted by specific drugs, giving certain patients access to drugs they wouldn't otherwise be able to access for their disease.

We spoke with Dr. Kim at the 2017 ASCO Annual Meeting because his institution is one of the lead sites participating in the TAPUR trial.